You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表现》启明医疗(02500.HK)暗盘收39.4元 较上市价高19.4%
阿思达克 12-09 18:34

根据辉立交易平台显示,明天挂牌的启明医疗-B(02500.HK)暗盘高开12%报37元,最高见39.45元,收报39.4元,高上市价19.4%或6.4元。成交759万股,涉资2.95亿元。不计手续费,每手500股,账面赚3,200元。

杭州启明是内地领先的经导管心脏瓣膜医疗器械商。是次来港上市共发售7,853.75万股H股,并已引入Hillhouse Capital、GIC、Aspex Master Fund、Cephei QFII China Total Return Fund及China Alpha Fund Management五名基石投资者,合共认购3,082.95万股H股;其中10%公开发售获逾311倍超购,已启动回拨机制占比增至50%,认购一手中签率仅30%;股份以招股范围(29-33元)上限定价,料集资净额24.11亿元,主要用作分配至核心/其他产品/在研产品、透过内部研究或潜在收购持续扩充产品组合提供资金、以及支付有关收购Keystone代价等。上市联席保荐人分别为高盛、中金、瑞信及招商证券。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account